TPST251017P00001000 Option on Tempest Therapeutics

TPST Stock  USD 10.24  0.28  2.66%   

Tempest Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

Tempest Total Stockholder Equity

Total Stockholder Equity

30.27 Million

At this time, Tempest Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year.

Tempest Therapeutics Corporate Management

Nicholas MaestasVP SecretaryProfile
Justin CPATreasurer ControllerProfile
Dr DubenskyPres DirectorProfile
Justin TrojanowskiTreasurer ControllerProfile
RAC SakaiHead QualityProfile
Samuel MDExecutive OfficerProfile
Petpiboon PrasitActing DirectorProfile

Additional Tools for Tempest Stock Analysis

When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.